Epidemiological Insights into TORCH Infections in the Population of Erbil City
Abstract
A seroepidemiological study of the TORCH panel was conducted on inhabitants of Erbil City to provide updated baseline data on TORCH prevalence. 508 individuals were included in this study. 218 (42.91%) were females and 290 (57.09%) were males. Their ages ranged from 13 to 63 year, the majority being within the age group (21-30 years), 162 (31.89%), (P < 0.05). 20 individuals (3.94%) tested positive for anti-TOX IgG antibodies. One of the 20 (5%) tested positive for anti-TOX IgM antibodies, who was a 32-year-old female. 128 individuals (25.2%) (all females) tested positive for anti-Rubella IgG antibodies. 40 individuals (7.87%) were positive for anti-CMV IgG antibodies. One of the 40 (2.5%) also tested positive for anti-CMV IgM antibodies, who was a 26-year-old male. 18 individuals (3.54%) tested positive for anti-HSV-1 IgG antibodies. One of the 18 (5.56%) also tested positive for anti-HSV-1 IgM antibodies. One 18-year-old male (0.2%) tested positive for anti-HSV-2 IgG antibodies, and none were positive for anti-HSV-2 IgM antibodies. The results suggest the presence of Toxoplasma, CMV, HSV-1 and HSV-2 infections among the community, the majority (P < 0.05) being CMV followed by TOX and HSV-1 and finally HSV-2. The positive IgG results of Rubella are most probably due to the obligatory vaccination program for females. Despite the fact that the majority of positive cases were for IgG, enhancing vaccination efforts and providing comprehensive health education is crucial for enhancing the well-being of the Erbil population.
Downloads
References
D. Fitzpatrick, N. E. Holmes and L. Hui. A systematic review of maternal TORCH serology as a screen for suspected fetal infection. Prenatal Diagnosis, vol. 42, no. 1, pp. 87-96, 2022.
J. Penner, H. Hernstadt, J. E. Burns, P. Randell and H. Lyall. Stop, think SCORTCH: Rethinking the traditional ‘TORCH’ screen in an era of re-emerging syphilis. Archives of Disease in Childhood, vol. 106, no. 2, pp. 117-124, 2021.
L. C. Wang, F. Yan, J. X. Ruan, Y. Xiao and Y. Yu. TORCH screening used appropriately in China?-three years results from a teaching hospital in Northwest China. BMC Pregnancy Childbirth, vol. 19, no. 1, p. 484, 2019.
J. M. Warnecke, M. Pollmann, V. Borchardt-Lohölter, A. Moreira- Soto, S. Kaya, A. G. Sener, E. Gómez-Guzmán, L. Figueroa- Hernández, W. Li, F. Li, K. Buska, K. Zakaszewska, K. Ziolkowska, J. Janz, A. Ott, T. Scheper and W. Meyer. Seroprevalences of antibodies against ToRCH infectious pathogens in women of childbearing age residing in Brazil, Mexico, Germany, Poland, Turkey and China. Epidemiology and Infection, vol. 148, p. e271, 2020.
A. Jaan and M. Rajnik. Torch complex. In: StatPearls. StatPearls Publishing, Treasure Island, FL, 2023. Available: https://www. statpearls.com/xyz123. [Last accessed on Jul 17, 2023].
P. Batra, M. Batra and S. Singh. Epidemiology of TORCH infections and understanding the serology in their diagnosis. Journal of Fetal Medicine, vol. 7, pp. 25-29, 2020.
Y. Liu, Y. Wu, F. Wang, S. Wang, W. Zhao, L. Chen, S. Tu, Y. Qian, Y. Liao, Y. Huang, R. Zhang, G. Xu and D. Zhang. The association between previous TORCH infections and pregnancy and neonatal outcomes in IVF/ICSI-ET: A retrospective cohort study. Frontiers in Endocrinology (Lausanne), vol. 11, p. 466, 2020.
L. Zhang, X. Wang, M. Liu, G. Feng, Y. Zeng, R. Wang and Z. Xie. The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study. PLOS Neglected Tropical Diseases, vol. 16, no. 10, p. e0010861, 2022.
J. J. Bigna, J. N. Tochie, D. N. Tounouga, A. O. Bekolo, N. S. Ymele, E. L. Youda and J. R. Nansseu. Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: A systematic review, modelling and meta-analysis. Scientific Reports, vol. 10, no. 1, p. 12102, 2020.
Y. Wang, S. Li, N. Ma, Q. Zhang, H. Wang, J. Cui and S. Wang. The association of ToRCH infection and congenital malformations: A prospective study in China. European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 240, pp. 336-340, 2019.
S. K. Matta, N. Rinkenberger, I. R. Dunay and L. D. Sibley. Toxoplasma gondii infection and its implications within the central nervous system. Nature Reviews Microbiology, vol. 19, no. 7, pp. 467-480, 2021.
L. Bollani, C. Auriti, C. Achille, F. Garofoli, D. U. De Rose, V. Meroni and C. Tzialla. Congenital toxoplasmosis: The state of the art. Frontiers in Pediatrics, vol. 10, p. 894573, 2022.
J. P. Dubey, F. H. A. Murata, C. K. Cerqueira-Cézar, O. C. H. Kwok and I. Villena. Congenital toxoplasmosis in humans: An update of worldwide rate of congenital infections. Parasitology, vol. 148, no. 12, pp. 1406-1416, 2021.
M. Deganich, C. Boudreaux and I. Benmerzouga. Toxoplasmosis infection during pregnancy. Tropical Medicine and Infectious Disease, vol. 8, no. 1, p. 3, 2022.
G. C. Milne, J. P. Webster and M. Walker. Is the incidence of congenital toxoplasmosis declining?” Trends in Parasitology, vol. 39, pp. 26-37, 2023.
K. K. Leung, K. L. Hon, A. Yeung, A. K. Leung and E. Man. Congenital infections in Hong Kong: An overview of TORCH. Hong Kong Medical Journal, vol. 26, no. 2, p. 127, 2020.
A. R. Mawson and A. M. Croft. Rubella virus infection, the congenital rubella syndrome, and the link to autism. International Journal of Environmental Research and Public Health, vol. 16, no. 19, p. 3543, 2019.
M. Leruez-Ville, I. Foulon, R. Pass and Y. Ville. Cytomegalovirus infection during pregnancy: State of the science. American Journal of Obstetrics and Gynecology, vol. 223, no. 3, pp. 330- 349, 2020.
M. L. Dietrich and J. S. Schieffelin. Congenital cytomegalovirus infection. Ochsner Journal, vol. 19, no. 2, pp. 123-130, 2019.
T. E. Deftereou, A. Trypidi, C. A. Alexiadi, P. Theotokis, M. E. Manthou, S. Meditskou, M. Simopoulou and M. Lambropoulou. Congenital herpes simplex virus: A histopathological view of the placenta. Cureus, vol. 14, no. 9, p. e29101, 2022.
F. E. Fuchs, M. Pauly, A. P. Black and J. M. Hübschen. Seroprevalenc of ToRCH pathogens in Southeast Asia. Microorganisms, vol. 9, p. 574, 2021.
K. M. Adams Waldorf and R. M. McAdams. Influence of infection during pregnancy on fetal development. Reproduction, vol. 146, pp. R151-R162, 2013.
E. A. Marcu, S. N. Dinescu, V. Pădureanu, F. Dumitrescu and R. Diaconu. Perinatal exposure to HIV infection: The experience of craiova regional centre, Romania. Healthcare (Basel), vol. 10, p. 308, 2022.
S. C. Cambrea, E. A. Marcu, E. Cucli, D. Badiu, R. Penciu, C. L. Petcu, E. Dumea, S. Halichidis, L. Pazara, C. M. Mihai and F. Dumitrescu. Clinical and biological risk factors associated with increased mother-to-child transmission of HIV in two South-East HIV-AIDS regional centers in Romania. Medicina (Kaunas), vol. 58, p. 275, 2022.
A. M. Al-Hakami, E. Paul, F. Al-Abed, A. A Alzoani, A. A. Shati, M. I. Assiri, A. A. Qasim, F. Riaz, R. A. Moosa and H. C. Chandramoorthy. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia. Saudi Medical Journal, vol. 41, no. 7, pp. 757-762, 2020.
X. Qin, S. Zhang, H. Liu, G. Cheng, Y. Liu, M. Hu, N. Liu and M. Zhang. Seroepidemiology of TORCH infections among 1.7 million women of childbearing age in rural China: A population based cross-sectional study. American Journal of Tropical Medicine and Hygiene, vol. 105, no. 5, pp. 1202-1209, 2021.
G. Pappas, N. Roussos and M. E. Falagas. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. International Journal for Parasitology, vol. 39, no. 12, pp. 1385-1394, 2009.
S. Wang, T. Wang, W. Zhang, X. Liu, X. Wang, H. Wang, X. He, S. Zhang, S. Xu, Y. Yu, X. Jia, M. Wang, A. Xu, W. Ma, M. M. Amin, S. R. Bialek, S. C. Dollard and C. Wang. Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China. Medicine (Baltimore), vol. 96, p. e6007, 2017.
M. Zuhair, G. S. A. Smit, G. Wallis, F. Jabbar, C. Smith, B. Devleesschauwer and P. Griffiths. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Reviews in Medical Virology, vol. 29, p. e2034, 2019.
Q. Zhou, Q. Wang, H. Shen, Y. Zhang, S. Zhang, X. Li and G. Acharya. Seroepidemiological map of Toxoplasma gondii infection and associated risk factors in preconception period in China: A nationwide cross-sectional study. Journal of Obstetrics and Gynaecology Research, vol. 44, pp. 1134-1139, 2018.
Q. Zhou, Q. Wang, H. Shen, Y. Zhang, S. Zhang, X. Li and G. Acharya. Seroprevalence of cytomegalovirus and associated factors among preconception women: A cross-sectional nationwide study in China. Frontiers in Public Health, vol. 9, p. 631411, 2021.
Q. Zhou, Q. Wang, H. Shen, Y. Zhang, S. Zhang, X. Li and G. Acharya. Rubella virus immunization status in preconception period among Chinese women of reproductive age: A nationwide, cross-sectional study. Vaccine, vol. 35, pp. 3076-3081, 2017.
T. Vilibic-Cavlek, S. Ljubin-Sternak, M. Ban, B. Kolaric, M. Sviben and G. Mlinaric-Galinovic. Seroprevalence of TORCH infections in women of childbearing age in Croatia. Journal of Maternal- Fetal and Neonatal Medicine, vol. 24, no. 2, pp. 280-283, Feb. 2011.
C. L. Radoi, O. Zlatian, M. Balasoiu, L. Giubelan, A. C. Stoian, L. Dragonu, A. Neacsu and D. G. Iliescu. Seroprevalence of infections with TORCH agents in Romania: A systematic review. Microorganisms, vol. 11, no. 8, p. 2120, 2023.
L. D. Samatova, A. B. Saidov, S. D. Bobozhonova, and K. R. Kuchkarova. Frequency of TORCH infection among the
donor population in the republican center for blood transfusion. E3S Web of Conferences, vol. 381, p. 01095, 2023.
E. Ç. Tanriverdi, L. Dikbaş, A. L. A. Y. Handan, B. G. Kadioğlu and Z. Özkurt. Seroprevalance of rubella antibodies among pregnant women in a regional maternity hospital in Eastern Turkey. Mediterranean Journal of Infection Microbes and Antimicrobials, vol. 7, p. 4, 2018.
S. Calimeri, A. Capua, V. la Fauci, R. Squeri, O. C. Grillo and D. L. Giudice. Prevalence of serum anti-rubella virus antibodies among pregnant women in Southern Italy. International Journal of Gynecology and Obstetrics, vol. 116, no. 3, pp. 211-213, 2012.
M. D. Amina, S. Oladapo, S. Habib, O. Adebola, K. Bimbo and A. Daniel. Prevalence of rubella IgG antibodies among pregnant women in Zaria, Nigeria. International Health, vol. 2, no. 2, pp. 156-159, 2010.
A. S. M. Juma, M. H. Ubeid and T. S. Salih. Anti-Toxoplasma, Anti-Rubella and Anti-CMV antibodies in dumpsite workers of Erbil governorate. Cihan University-Erbil Scientific Journal, vol. 3, no. 1, pp. 85-89, 2019.
T. S. Salih, A. S. M. Juma and M. H. Ubeid. Occupational exposures and associated health effects among dumpsite workers: A case study of Kani Qirzhala Landfill Site, Erbil, Iraq. Cihan University- Erbil Scientific Journal, vol. 5, no. 2, pp. 1-5, 2021.
M. H. Ubeid, T. S. Salih and A. S. M. Juma. HIV, HBS and HCV in dump Site workers of Erbil governorate. Cihan University-Erbil Scientific Journal, vol. 5, no. 2, pp. 20-23, 2021.
Copyright (c) 2024 Ameena S.M. Juma, Kamgar A. Rasul, Muhsin H. Ubeid, Shakir M. Al-Awqati, Tanya S. Salih, Muhamed A. Abbas
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).